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Background: Physical and pharmacological restraints, defined as all measures limiting a
person in his or her freedom, are extensively used to handle unsafe or problematic
behavior in hospital care. There are increasing concerns as to the extent with which these
restraints are being used in hospitals, and whether their benefits outweigh their potential
harm. There is currently no comprehensive literature overview on the beneficial and/or
adverse effects of the use of physical and pharmacological restraints in the
hospital setting.
Methods: A systematic review of the existing literature will be performed on the beneficial
and/or adverse effects of physical and pharmacological restraints in the hospital setting.
Relevant databases will be systematically searched. A dedicated search strategy was
composed. A visualization of similarities (VOS) analysis was used to further specify the
search. Observational studies, and if available, randomized controlled trials reporting on
beneficial and/or adverse effects of physical and/or pharmacological restraints in the
general hospital setting will be included. Data from included articles will be extracted and
analyzed. If the data is suitable for quantitative analysis, meta-analysis will be applied.
Discussion: This review will provide data on the beneficial and/or adverse effects of the
use of physical and pharmacological restraints in hospital care. With this review we aim to
guide health professionals by providing a critique of the available evidence regarding their
choice to either apply or withhold from using restraints. A limitation of the current review
will be that we will not specifically address ethical aspects of restraint use. Nevertheless,g February 2020 | Volume 10 | Article 9211
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Frontiers in Psychiatry | www.frontiersin.orthe outcomes of our systematic review can be used in the composition of a
multidisciplinary guideline. Furthermore, our systematic review might determine
knowledge gaps in the evidence, and recommendations on how to target these gaps
with future research.
Systematic Review Registration: PROSPERO registration number: CRD42019116186.Keywords: physical restraint, pharmacological restraint, chemical restraint, hospital, adverse effects,
complications, behavioral issues, systematic review protocolINTRODUCTION
Rationale
Physical and pharmacological restraints are still being used
extensively by health professionals in general hospital care (1–4).
Physical and pharmacological restraints can be defined as measures
that limit a person in his or her freedom (5). Physical restraints are
any action or procedure that prevents a person’s free body
movement to a position of choice and/or normal access to his/her
body by the use of any method, attached or adjacent to a person’s
body that he/she cannot control or remove easily (4, 6). Examples of
physical restraints range from applying the brakes on a wheelchair
or raising the bed rails, to using an abdominal restraint (5, 7–9).
Even though considered less invasive, methods such as using video,
mechanical (e.g., seat exit alarms), or acoustical surveillance are also
seen as restraints (10). Pharmacological, also called chemical,
restraints are a form of restraint in which drugs are used to
restrain patients. Although no consensus definition exists, they
can be defined as either the deliberate or incidental use of
pharmaceutical products to control a person’s behavior and/or to
restrict his or her freedom of movement, when they are not
exclusively intended to treat a medical condition (8, 11).
Medicaments such as benzodiazepines and antipsychotics, that are
commonly used in psychiatric practice, for example in, respectively,
the treatment of insomnia and the treatment of psychosis, are also
used as pharmacological restraints due to their sedative effects.
Physical and pharmacological restraints are mostly used when a
patient shows behavior that compromises his or her own safety and
that can cause serious physical or mental injuries, or compromises
the safety of others (4, 12). Examples of this behavior range from
wandering and making repetitive or disturbing noises to agitated
and aggressive behavior or even suicidality (13, 14). If used properly,
restraints are only used in cases where there is no alternative and less
invasive measure possible. Moreover, only the least invasive or
restraining measure that is effective in a given situation should be
used (5, 9).ing; AMT, Abbreviated Mental Test;
avioral Activity Rating Scale; CAM,
DE, Grading Recommendations
; ICTRP, International Clinical Trials
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g 2In the last few years, medical, ethical, and political concerns
have increasingly risen about the extent with which restraints are
used in hospitals and whether their beneficial effects outweigh
their potential harm (1–4, 15). Potential harm associated with
restraints is numerous, for example, malnutrition, bed sores,
incontinence, contractures, falling, as well as mental
deterioration and worsening of the behavior that was the
reason to use the restraint in the first place (5, 9, 16). The use
of restraints is also known to have a negative psychological
impact on patients, provoking feelings of fear or anger, as well as
feelings of embarrassment and the experience of loss of dignity
(2, 16). Furthermore, the evidence on the benefits of restraints is
not convincing, e.g., restraints do not always seem to be effective
in reducing falls, or in preventing patients from removing their
medical devices (4, 17, 18). A majority of the patients admitted to
hospitals nowadays are elderly. Elderly patients are one of the
patient groups with a higher risk to experience physical or
pharmacological restraints (9). Furthermore, they are also
more prone to suffer from the adverse consequences of these
restraints than younger patients. Restraints may even increase
the chance of physical or mental harm, instead of reducing it,
particularly in the elderly (9). Considering the potential harm
and the fact that the evidence suggests that restraints are not
unequivocally effective in preventing the harmful situations they
were indicated for in the first place, the question is whether
restraint use is ethically justifiable. Moreover, restraints always
imply a far-reaching restriction of personal freedom and are
often applied in situations where patients are not able to give
permission for the intervention themselves, and where one has to
rely on permission from a guardian (19, 20). In the Netherlands,
these concerns have gained attention in the political setting and
have recently led to the development of a new quality indicator
on the use of restraints and an update of the law on coercion in
care (15, 21). In some other countries, e.g., the United Kingdom
and Iceland, the use of restraints is even already restricted or
prohibited in certain settings (22).
Currently, there is no comprehensive literature overview on
the beneficial and/or adverse effects of the use of physical and
pharmacological restraints in the hospital setting. Therefore,
health professionals that are being confronted with unsafe or
problematic behavior lack evidence based guidance. Hospitals in
the Netherlands have constructed their own guidelines, but there
is no national or international consensus on how and when to
use physical or pharmacological restraints in hospitals.
Importantly, there are signs that the hospitals’ own guidelines
are not always used appropriately when applying restraints. InFebruary 2020 | Volume 10 | Article 921
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followed a guideline while using a restraint on a patient (3). In a
Belgian study, only 26.9% of participating physicians used
guidelines for the pharmacotherapeutic management of
agitation (23). Furthermore, it was recently shown that most of
the nurses participating in a study did not understand the
reasons for restraint use (24). The lack of available evidence
based guidance may cause uncertainty in the practice of applying
restraints and wrongful use of restraints.
In conclusion, there seems to be a gap between new
developments and increasing attention for reducing restraints
in hospitals on the one hand, and a lack of evidence based
practice for using restraints on the other hand. In this project,
we aim to address this gap by systematically reviewing the
available literature on the beneficial and/or adverse effects of
the use of physical and pharmacological restraints in the
hospital setting.
Objectives
Our main objective is to systematically accumulate and
critically review the available evidence on the beneficial and/
or adverse effects of different physical and pharmacological
restraints in the hospital setting. We intend to do this by
collecting evidence on different outcomes that report
information on either a beneficial or an adverse effect of the
use of restraints. For example, both a shorter length of hospital
stay for restrained patients, as well as a shorter time for a patient
to reach a state of tranquillity after administration of a
pharmacological restraint implicate a beneficial effect of the
use of restraint. In contrast, a high rate of complications (e.g.,
falls, adverse drug events, or agitation) occurring in patients
that were in restraints during their hospital stay implicates an
adverse effect of the use of restraints.METHODS
Review Method
This systematic review protocol was drafted according to the
preferred reporting items for systematic review and meta-
analysis protocols (PRISMA-P) 2015 statement (25). The
preferred reporting items for systematic review and meta-
analysis (PRISMA) checklist will be used throughout the
process of drawing up the systematic review (26). The protocol
is registered in the PROSPERO international prospective register
of systematic reviews.
Eligibility Criteria
In this section, we specify the criteria by which we will select the
studies that will be included in the systematic review.
The first criterion for inclusion we are considering is the study
design. We will be including observational studies, e.g.,
prospective and retrospective cohort studies, case-control
studies, cross-sectional studies, case series with sample sizes
equal to or larger than 10, as well as experimental studies if
available, e.g., randomized controlled trials. By surveyingFrontiers in Psychiatry | www.frontiersin.org 3relevant literature, we expect that most available studies will be
observational studies, while experimental studies are not
expected to be widely available.
Another criterion we will be selecting studies on is the setting
the studies are conducted in. Participants in studies should be
admitted to the hospital. We define the hospital setting as all
medical wards of general hospitals, including but not limited to
surgical or geriatric wards, and emergency departments of
general hospitals. Studies including patients admitted to
intensive care units (ICU) will be excluded considering an
ongoing review of another research group specifically on that
subject (27). Moreover, we exclude this group considering it is a
different population admitted in distinct conditions, which are
not generalizable to other wards of a general hospital. Also
studies conducted on psychiatric wards will be excluded, given
that these studies address a specific patient group and care setting
that does not generalize to the general hospital. Studies not
conducted in general hospitals will be excluded. Consequently,
we will exclude studies conducted in nursing homes and other
long term care facilities, as well as studies conducted in psychiatric
institutions or psychiatric hospitals. We exclude these settings
considering the already available evidence on the subject in these
settings (28–30). Studies that contain data from general hospitals
as well as nursing homes or other care facilities will be used if they
clearly separate the results for each setting, or if these results can
be provided separately by the authors of these studies.
The next selecting criterion is the intervention that studies
look in to. The intervention we are interested in is the use of
physical or pharmacological restraints. These restraints have to
be used with the intention to aid the safety of the patient and its
surroundings, for example, when a patient shows behavior that
compromises his or her own safety or the safety of others and
that can cause serious physical or mental injury. We will not
include studies using physical or pharmacological interventions
that are applied exclusively with the intention to treat a disease or
disorder, e.g., antipsychotics prescribed with the intention to
treat a delirium, restricting or forcing dietary intake in case of,
e.g., refeeding, or benzodiazepines prescribed with the intention
to treat sleeping disorders or alcohol withdrawal. The
comparators we are interested in are either no use of physical
or pharmacological restraints, use of alternative measures instead
of physical or pharmacological restraints, or use of less invasive
or restraining physical or pharmacological restraints. Specifically,
if the literature allows, pharmacological restraints are compared
either to a placebo or to other pharmacological restraints, e.g.,
antipsychotics compared to benzodiazepines or a placebo. For
physical restraints, a multitude of different comparisons can be
made. For example, comparisons between standard restraints
and less invasive restraints such as bed- or seat exit alarms,
motion detectors, or acoustical surveillance. Furthermore,
comparisons between standard restraints and new, possibly
safer and more effective restraints, such as safe enclosures.
Another possibility is a comparison between access to a bed-
or seat exit alarm versus no access to such an alarm. Also
expected to be available are studies looking into associations
between restraint and other factors, such as delirium or falls. ForFebruary 2020 | Volume 10 | Article 921
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restraint in a group of patients suffering from delirium
compared to a group of patients without delirium.
Another important criterion for selection of studies are the
study outcomes. To provide a structured overview of our
outcomes of interest, we listed our outcomes of interest in
Table 1. A further elaboration on the outcomes is described
below in the Outcomes and Prioritization section.
Other study characteristics we will take into account while
conducting the selection process are timing, geographical setting,
and language. We will include articles published from inception to
the present date. We will include studies in the English and Dutch
language. If relevant studies in other languages are available, they
can be used, providing that there is a usable translation. There are
no restrictions for the geographical locations the studies are
conducted in.We will include studies that have been fully published.Frontiers in Psychiatry | www.frontiersin.org 4Information Sources
The information sources we will use are the MEDLINE, Embase,
and PsycINFO databases. In addition, we will scan reference lists
of included studies and relevant guidelines to ensure that no
relevant studies will be excluded from the review.
Search Strategy
We have consulted an experienced medical information
specialist for composing the search strategy. Firstly, we
performed a scoping search in Google Scholar, including
backward and forward reference citation analyses and similar
article searches in PubMed. This yielded reference sets on the
subjects of physical restraints and pharmacological restraints.
To further optimize the search, we composed a
comprehensive list of physical restraints and problem behavior
types and synonyms using related guidelines, overview articles,
and a consultation of a clinical neuropsychologist (7, 9, 13, 14,
31–38).
A dedicated search strategy combining text words and
medical subject headings (MeSH) was composed for the
MEDLINE database. Subsequently, a visualization of
similarities (VOS) analysis was conducted using VOS viewer
software (39) on the MEDLINE search results in order to
identify candidate terms for notting out of the search strategy,
to further specify the search. Figure 1 shows the density
visualization of the VOS analysis. Consequently, by scanning
the resulting network, we excluded several search terms that
would yield irrelevant studies for our search. The search
strategy was adjusted by excluding the irrelevant terms.
Exclusion of these irrelevant terms was checked in sensitivity
searches. Subsequently, the MEDLINE search strategy was
adjusted for the Embase and PsycINFO databases. The final
search strategy is a sensitive compilation of terms describing the
setting, the problem behavior that can cause the need for
restraints and the types of restraints included, physical as well
as pharmacological. For a comprehensive overview of the search
terms used, we refer to the search strategy itself, added in
Supplementary File 1. The final search will be repeated in the
later stages of the systematic review to ensure the most recent
publications will not be disregarded.
Study Records
Data Management
The systematic review data management software application we
will be using for eligibility screening of references is Rayyan (40).
The search records will be checked for duplicates. Endnote will
be used for bibliographic records management.
Selection Process
Two reviewers will take part in the selection process of studies.
They will both screen all articles resulting from the search by title
and abstract, independently from each other. Articles that appear
to meet the inclusion criteria will be screened full text by each
independent reviewer and will be reviewed for suitability using
existing dedicated evaluation instruments for critically and
systematically appraising articles. Also articles from which it isTABLE 1 | Outcomes of interest.
Primary outcomes
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abstract screening will be screened full text by each independent
reviewer and reviewed for suitability. Disagreements in the
inclusion of articles arising from the title-abstract screening, as
well as from the full text screening will be solved by discussion. If
no agreement can be reached, a third independent researcher will
be consulted to solve the disagreement. The review authors will
not be blinded to any article information (such as journal names
or author names).
Data Collection Process
A form to extract data from articles will be drawn up, tested, and
used. We will elaborate on the data we will be extracting in Data
Items section. The data extraction will be conducted by one
reviewer, and verified by another reviewer. Disagreements will be
sorted by discussion, and if no agreement can be reached a third
independent researcher will be consulted. In case of uncertainties
regarding the data or missing data the authors will be contacted
via email for clarification or addition.
Data Items
Data items we will be extracting include article information, such
as year of publication, author(s), title, and journal name. We will
also extract data on study characteristics, such as study design,
e.g., observational studies or randomized controlled trials, and
study setting, specifically the type of hospital ward, or an
emergency department. Data will be extracted on the
indications for restraint use, as well as data on the study
interventions used, such as the use of physical restraint, or theFrontiers in Psychiatry | www.frontiersin.org 5use of pharmacological restraint. Subsequently, we will also
include the study comparators used, such as no use of
restraints, or the use of alternative measures. Furthermore, we
will extract data on participant characteristics, such as average
age, gender and the reason for admission to the hospital. We will
also extract data on our outcomes of interest (Table 1). Finally,
we will extract data on the type of sponsoring the studies had and
their publication status.
Outcomes and Prioritization
As mentioned before, in this section, we will elaborate on our
outcomes of interest, as listed in Table 1. Starting with our
primary outcomes of interest, for this review, we are interested
in the effects of the use of physical or pharmacological restraints
on the patient. We are interested in both beneficial and adverse
effects of the use of restraints. We will firstly examine these
effects using our primary outcome variables “length of hospital
stay” and “complication rate”. The length of hospital stay can,
depending on the value, imply a beneficial or an adverse effect.
If there is a shorter length of hospital stay when using restraints
compared to when not using restraints, this can imply a
beneficial effect of the use of restraints, while if the length of
hospital stay is longer an adverse effect of the restraint use might
be implied. The length of stay will be measured in days. A
higher complication rate also indicates adverse effects of the use
of restraints. We intend to evaluate the overall complication
rate, considering some studies will only report on the outcome
complications, and will not distinguish the type of
complications that have occurred. Additionally, we intend toFIGURE 1 | Visualization of similarities density visualization(39).February 2020 | Volume 10 | Article 921
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do make a distinction. By surveying relevant literature, we
found that complications can be arranged into several
categories. Categories and respective tools of measurement
include, cognitive performance, measured by, e.g., the Mini-
Mental State Examination (MMSE) (41) or the Abbreviated
Mental Test (AMT) (42, 43), behavioral problems, measured by,
e.g., the Agitated Behavior Scale (ABS) (44), the Behavioral
Activity Rating Scale (BARS) (45), the Richmond Agitation-
Sedation Scale (RASS) (46), or the Confusion Assessment
Method (CAM) (47), rate of falls, walking and other activities
of Daily Living (ADL) dependence, measured, e.g., by the
Modified Barthel Index (MBI) (48, 49), rate of pressure ulcers
and rate of contractures (7). Articles tend to split the adverse
effects in physical and mental health problems. We intend to
use validated tools of measurement, if available.
Regarding the beneficial outcomes of restraint use, we are
interested in the success rate of the restraint application, i.e., the
percentage that the restraint has been effective, e.g., in controlling
the behavior it was applied for. Two measures that are being used
to specify this outcome are “time to tranquility or time to
sedation,” as evaluated by different measurement tools, e.g.,
BARS, the ABS, or the RASS, and the need for additional
restraints. The time (in minutes) until a certain threshold on
the behavioral rating scale has been reached is assessed from the
application of the restraint.
Secondarily, we are interested in the survival. This can give
information on a beneficial or adverse effect of the use of
physical or pharmacological restraints. For example, if the
duration of survival of patients that were restrained at some
point in the treatment is shorter than that of similar patients
that were not restrained, it can indicate an adverse effect of
the restraint.
Another secondary outcome of interest is symptom severity,
split into physical and psychiatric symptoms. This will give
information about the effects of the restraint on symptoms.
We are also interested in the effects of the use of physical or
pharmacological restraints for the health care system in general.
We are interested in the effects on health care providers who deal
with applying restraints, such as physicians and nurses. We are
also interested in the effect on the health costs. Moreover, we
intend to review data on the cost effectiveness of the use
of restraints.
Risk of Bias in Individual Studies
The risk of bias will be assessed by one reviewer, and verified by
another reviewer. Disagreements will be sorted by discussion, if
no agreement can be reached a third independent researcher
will be consulted. The risk of bias will be assessed by using
dedicated tools such as the latest version of the Cochrane
Collaboration Tool for assessing risk of bias (50), or the
Newcastle-Ottawa scale (NOS) (51), depending on the type of
articles included.
We will not exclude any articles according to risk of bias.
Because of the small number of available articles expected on thisFrontiers in Psychiatry | www.frontiersin.org 6subject, we want to include all available evidence. However, we
will carefully document risk of bias and consider the risk of bias
while interpreting the results.
Data Synthesis
Criteria Under Which Data Will Be Quantitatively
Synthesized
If studies are sufficiently homogeneous, a meta-analysis will be
conducted on the collected data, using a random-effects model in
the software program Comprehensive Meta-analysis. Whether or
not a meta-analysis is possible will become apparent after data
extraction. Also, if certain groups of studies are sufficiently
homogeneous, due to the diversity of outcomes, we are
including, we will conduct a meta-analysis on part of the
included studies.
Planned Methods for Summarization, Handling Data
and Combining Data
We aim at comparing the different interventions and
comparators listed in Data Items section, depending upon
study availability. We will compare restraints with all available
comparators including no intervention. This implies that, if two
different forms of restraints are compared, we will compare these
restraints to investigate their beneficial and adverse effects, e.g.,
benzodiazepines vs. antipsychotics. We will summarize all
extracted data using tables and where possible graphs. If we
come across missing data, we will contact the study authors to
attempt to obtain the missing data. Assessment of heterogeneity
will take place using relevant tests.
Proposed Additional Analysis
If deemed relevant, meta-regression analysis can be used to
explain differences in outcomes between studies and subgroups.
Type of Summary Planned If Quantitative Synthesis
Is Not Appropriate
If the data or part of the data is not suitable to conduct
quantitative tests, those results will be presented in a narrative
form using text and tables. The resulting systematic narrative
synthesis will provide an overview of the characteristics and
results of the included studies using tables. It will also provide a
narrative comparison of the findings of the different studies,
thereby finding similarities and differences between the studies.
Meta-Bias(es)
To determine whether outcome reporting bias is present, we will
check as to whether selective reporting of outcomes is present in
included studies by screening protocols in the International
Clinical Trials Registry Platform (ICTRP) of the World Health
Organization (WHO) (52). If no protocol is available we will
compare the method section to the results section. We will also
have to take into account selection bias, considering we will
include observational non-randomized studies, which are
especially susceptible to selection bias. Since non-randomized
studies are also susceptible to performance bias and detectionFebruary 2020 | Volume 10 | Article 921
de Bruijn et al. Restraints in Hospital Carebias, we will also check for these biases. In case there are
withdrawals from studies, we will check for attrition bias. We
will also check for publication bias and small sample bias
where possible.
Confidence in Cumulative Evidence
The strength of the body of gathered evidence will be weighed
according to theGRADEmethodology (Grading Recommendations
Assessment, Development and Evaluation) (53).DISCUSSION
This project aims to systematically review the available literature
on the beneficial and adverse effects of the use of physical and
pharmacological restraints in hospital care. Our objective is to
assemble the available evidence on this subject, and to
subsequently provide a critical assessment of the gathered
evidence. Results of our review may more optimally guide
health professionals in their choice when to refrain from
applying restraints in the hospital and to use restraints in a
correct way. Additionally, the outcome of our review might aid
health professionals in properly discussing the subject of
restraints with patients and relatives. Moreover, results will
identify knowledge gaps that need to be targeted in order to
bring about changes to the daily clinical practice of restraints.
In nursing homes and other non-hospital settings, there
have been gradual advances in limiting the use of restraints. For
these settings, guidelines and literature overviews have been
synthesized and implemented (54–62). For example, in nursing
homes throughout the United States, there have already been
positive results in reducing the use of restraints, limiting the use
of restraints in nursing homes from 40% in the 1980s to 10% in
2008 (7). While restraint use in nursing homes may be reduced
even further, these results hold promise for the reduction of
restraints in the hospital setting. Moreover, we will not address
the use of restraints in psychiatric care facilities. These
restraints are usually being applied under a different legal
system, which makes it difficult to compare outcomes.
Nevertheless, restraints used on psychiatric patients in general
hospitals (excluding the psychiatric ward) will be included in
the current review.
One of the limitations inherent to all systematic reviews is
the amount of evidence available. In our scoping search, we
encountered a small amount of studies that focus specifically on
the hospital setting. Effects of restraints in the nursing home
setting have been better studied, but it remains unknown as to
what extent this evidence translates to the hospital setting (28,
30, 63). For the psychiatric setting, evidence on the effects of
restraints is also available, although reviews by Nelstrop and
Sailas stated the lack of experimental studies as an important
limitation (29, 64, 65). Both the patient population (including,
e.g., mental and physical health) and the setting (e.g., the
amount and qualifications of staff, the architecture of the
ward) may cause differences in the effects of restraints inFrontiers in Psychiatry | www.frontiersin.org 7the hospital vs. the nursing home setting. Reviewing the
available evidence for the hospital setting therefore seems
important to provide health professionals in hospitals with
clinically relevant effect estimates regarding the use of
restraints. Moreover, the quality of the evidence may limit the
conclusions that can be drawn. Given the expected lack of
RCTs, residual confounding or reverse causation may induce
biases. Nevertheless, conclusions form the best available
evidence may inspire future (non-inferiority) RCTs on the
effects of restraints in the hospital.
In our scoping search on pharmacological, or chemical,
restraints, we found that these terms are used rather sparsely
to identify relevant literature. Moreover, we found that not all
studies on pharmacological restraints use either the term
pharmacological or chemical restraint. This proposed
difficulties in composing a comprehensive, but not too broad,
search strategy. By additionally including search terms on
specific psychopharmacological interventions that may be used
as chemical restraint (e.g., benzodiazepines, antipsychotics, and
opioids), we aimed at including all relevant evidence. Another
difficulty we encountered l ies in the definit ion of
pharmacological restraint that we use. Namely, in the
introduction, we stated that the pharmaceutical products used
as pharmacological restraints cannot be used to treat a medical
condition. However, the distinction between treatment of a
medical condition and use as a restraint will not always be
clear. For example, when treating a psychotic disorder
accompanied by aggressive behavior with an antipsychotic
drug, the aim of the treatment can be twofold. On the one
hand, the aim is to treat the psychosis, and on the other hand, the
sedative effect the antipsychotic has can reduce the aggressive
behavior. We will critically examine whether this distinction is
clear in the studies we include, and take this into account when
interpreting the data. Nevertheless, this difficulty in
differentiation between treatment vs. chemical restraint
remains a potential limitation of this study.
We will not specifically address measures that are used as an
alternative to restraints on their own. Nevertheless, we will
include all studies that compare the effects of physical or
chemical restraints to specific alternatives that consist of
domotics (home automation) or psychological interventions.
Another example of such an alternative measure is the
presence of a relative to calm a disquieted patient, also called
“rooming in.” Considering the idea that benefits of restraints
might not outweigh their adverse effects, these measures might
provide a viable alternative. Results of our systematic search may
determine as to which extent it is more beneficial and safer to
apply these interventions instead of restraints, in which the
experiences of both patients and their relatives are important
(10, 66–68).
A topic that will not be addressed by this systematic review is
the ethical aspect of applying restraints. Cultural differences in
the view on restraints may influence the way the beneficial and
adverse effects of restraints are being evaluated. Moreover,
political forces may impose clinical decisions that are not in
line with available evidence. Nevertheless, outcomes of theFebruary 2020 | Volume 10 | Article 921
de Bruijn et al. Restraints in Hospital Carecurrent review may form an important contribution to the
(ethical) debate on the application of restraints in the hospital.
Regarding dissemination of the results of our systematic
review, we plan to submit results for publication in peer
reviewed scientific journals. Moreover, we intent to present
findings at meetings of relevant scientific societies. In addition,
literature databases and curated extracted data will be available
for interested collaborators on request. Finally, we will write a
report for the funding organization, as commissioned by the
Dutch Ministry of Health, Welfare and Sport.
In conclusion, with this systematic review protocol, we
describe the methodology of our systematic search on the
beneficial and adverse effects of physical and chemical
restraints in the hospital. We hope that this review will provide
health professionals with evidence based knowledge to better
guide their choice to apply or refrain from restraints. If the
notion is correct, in that for most indications negative effects of
restraints outweigh their positive effect, this may lead to a
reduction in the use of restraints in the hospital, as has already
been achieved in nursing homes. In addition, by addressing
knowledge gaps, this review will direct future research that is
needed to improve the clinical application of restraints.
Moreover, the outcomes of our systematic review can be used
in the composition of a multidisciplinary guideline.Frontiers in Psychiatry | www.frontiersin.org 8AUTHOR CONTRIBUTIONS
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